The VEGFR2 expression scores in the tumor cells in ADC and SCC were not statistically different (p = 0.1238), although the trend for higher incidence of tumor cell immunoreactivity in SCC is in line with our initial observations in the multi-tumor screening cohort that comprised SCCs of various organs, including lung (Table 2). This evidence concerns the gene KDR and neoplasm.